Management of Disseminated Intravascular Coagulation (DIC) with Active Bleeding

Laboratory Profile Analysis and Replacement Therapy

The American Society of Hematology recommends fibrinogen replacement when levels are below 1.5 g/L, as seen in this patient with a fibrinogen level of 1.49 g/L, indicating a high risk of bleeding and need for urgent correction 1, 2, 3
A fibrinogen level <1.0 g/L is highly suggestive of DIC and requires urgent correction, with this patient's level being just below the critical threshold 8, 4
The International Society on Thrombosis and Haemostasis suggests that a D-dimer level of 121,000, as seen in this patient, indicates massive fibrin formation and breakdown, consistent with DIC 4
The critically low platelet count of 15,000/μL in this patient requires urgent transfusion to maintain a platelet count >50 × 10⁹/L in the setting of active bleeding 5, 1, 3

The American College of Chest Physicians recommends administering Fresh Frozen Plasma (FFP) at 15-25 mL/kg immediately in the setting of active bleeding with prolonged PT and low fibrinogen, with a goal to maintain PT ratio <1.5 and correct multiple coagulation factor deficiencies 1, 2
The British Society for Haematology suggests that cryoprecipitate or fibrinogen concentrate should be administered immediately if fibrinogen is <1.5 g/L despite active bleeding, as seen in this patient 1, 2, 3
The American Society of Hematology recommends transfusing 4-8 single platelet units (or one apheresis pack) to maintain a platelet count >50 × 10⁹/L in the setting of active bleeding 5, 1, 3

The European Society of Intensive Care Medicine suggests that if volume overload is a concern, 4-factor Prothrombin Complex Concentrate (PCC) can be considered instead of or in addition to FFP, providing concentrated coagulation factors without large fluid volumes 1, 2, 7

The American College of Chest Physicians recommends rechecking coagulation studies (PT/INR, fibrinogen, platelet count) within 1-2 hours after initial replacement therapy, as laboratory values in DIC change rapidly due to ongoing consumption 7, 4

The International Society on Thrombosis and Haemostasis emphasizes the importance of simultaneously investigating and treating the underlying cause of DIC, as this is the cornerstone of DIC management 4, 3